These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3825276)

  • 1. [Protective effect of phosphocreatine on the myocardium (experimental study)].
    Afonskaia NI; Sharov VG; Ruda MIa; Vikhert AM; Cherpachenko NM
    Vestn Akad Med Nauk SSSR; 1986; (12):50-8. PubMed ID: 3825276
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of the protective effect of phosphocreatine on the ischemic myocardium during cardioplegia using the P-31 NMR method].
    Kupriianov VV; Shteĭnshneĭder AIa; Lakomkin VL; Ruuge EK; Kapel'ko VI
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(1):14-9. PubMed ID: 4005052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phosphocreatine in the protection of the myocardium in cardioplegic arrest; biochemical and functional aspects in the dog].
    Bricco G; Piacenza G; Borgoglio R; Zamperone O; Sguazzi P
    Cardiologia; 1986 Jul; 31(7):509-14. PubMed ID: 3568043
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic factors in the development of myocardial necrosis and micro-infarcts.
    Fleckenstein A
    Triangle; 1975; 14(1):27-36. PubMed ID: 1162727
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic changes in infarcted and non-infarcted myocardium during the postinfarction period.
    Gudbjarnason S; Ravens KG; Mathes P
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():439-46. PubMed ID: 4681474
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ultrastructural basis of acute cardiac insufficiency not associated with rhythm disorders].
    Sharov VG; Orlova TsR; Saks VA
    Arkh Patol; 1978; 40(10):3-14. PubMed ID: 367323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hypercholesterolemia on the macroergic content and size of necrotic area in the heart muscle in acute coronary occlusion in rabbits].
    Irgashev ShB; Iuldashev NM
    Patol Fiziol Eksp Ter; 1987; (3):62-4. PubMed ID: 3627838
    [No Abstract]   [Full Text] [Related]  

  • 8. [Creatine phosphate: an additive to cardioplegic solutions. Clinical study].
    D'Alessandro LC; Cini R; Stazi G; Pucci A; De Benedictis F; Rabitti G; Benhar M; Giacopino F; Pezza E; Cioli G
    Cardiologia; 1987 Mar; 32(3):307-13. PubMed ID: 3607801
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sodium phosphocreatine and platelet aggregation. Experimental research in vivo and in vitro].
    Somma A; Vairo G; Chieppa S; Luppino E; Pierri T; Giasi M; Matera G; Laudando G; Marmo E
    Arch Sci Med (Torino); 1981; 138(3):399-402. PubMed ID: 7316744
    [No Abstract]   [Full Text] [Related]  

  • 10. The superiority of blood cardioplegia in myocardial preservation.
    Engelman RM; Rousou JH; Dobbs W; Pels MA; Longo F
    Circulation; 1980 Aug; 62(2 Pt 2):I62-6. PubMed ID: 7397998
    [No Abstract]   [Full Text] [Related]  

  • 11. Biochemical changes in non-infarcted heart muscle following myocardial infarction.
    Gudbjarnason S; Mathes P
    Recent Adv Stud Cardiac Struct Metab; 1973; 2():581-9. PubMed ID: 4806989
    [No Abstract]   [Full Text] [Related]  

  • 12. [State of the myocardium outside the infarct zone].
    Vikhert AM; Cherpachenko NM
    Ter Arkh; 1981; 53(4):38-49. PubMed ID: 6167006
    [No Abstract]   [Full Text] [Related]  

  • 13. The pharmacology of disopyramide.
    Nayler WG
    J Int Med Res; 1976; 4(1 Suppl):8-12. PubMed ID: 1026534
    [No Abstract]   [Full Text] [Related]  

  • 14. [Energy-rich phosphorus compounds, and creatinase and ATPase activity of the heart muscle in experimental myocardial infarction].
    Khauatrian LL; Abaturova NA
    Vopr Med Khim; 1965; 11(3):26-31. PubMed ID: 4223588
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of energy transfer in ischemic heart muscle.
    Gudbjarnason S
    Recent Adv Stud Cardiac Struct Metab; 1972; 1():17-26. PubMed ID: 4681461
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of experimental coronary artery reperfusion. Effects on infarct size, myocardial function, biochemistry, ultrastructure and microvascular damage.
    Kloner RA; Ellis SG; Lange R; Braunwald E
    Circulation; 1983 Aug; 68(2 Pt 2):I8-15. PubMed ID: 6861331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intravenously administered phosphocreatine on ATP and phosphocreatine concentrations in the cardiac muscle of the rat.
    Down WH; Chasseaud LF; Ballard SA
    Arzneimittelforschung; 1983; 33(4):552-4. PubMed ID: 6683532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic and inotropic effects of O-benzyl-phosphocreatine in rabbit myocardium.
    Tuganowski W
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Sep; 350(3):310-4. PubMed ID: 7824048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Energy metabolism of the heart during infarct healing].
    Braasch W; Gudbjarnason S; Bing RJ
    Verh Dtsch Ges Kreislaufforsch; 1968; 34():280-7. PubMed ID: 5736277
    [No Abstract]   [Full Text] [Related]  

  • 20. Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction.
    Skyschally A; Gres P; Hoffmann S; Haude M; Erbel R; Schulz R; Heusch G
    Circ Res; 2007 Jan; 100(1):140-6. PubMed ID: 17170366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.